Company intelligence / Profile preview

Pulsenmore

Omer, Southern District, Israelpulsenmore.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Pulsenmore’s self-scan home ultrasound platform has been clinically validated with over 120,000 at-home scans performed. The solution reduces maternal anxiety and clinical visits while improving patient satisfaction. It has received CE mark approval in Europe and regulatory clearance in Israel and Brazil; FDA review ongoing.

Therapeutic areas: Women's Health
Modalities: DeviceNon-pharmacological therapy (remote monitoring)Digital health platform
Industry: Digital Health Medical Devices

Partnerships

GE Healthcare (strategic investment & global commercialization partnership)Clalit Health Services (Israel’s largest HMO) – implementation partner

Beyond the preview

Go deeper on Pulsenmore.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pulsenmore.

Explore the full profile